Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Internet Patient Decision Support

Internet Patient Decision Support ORIGINAL INVESTIGATION A Randomized Controlled Trial Comparing Alternative Approaches for Men Considering Prostate Cancer Screening Dominick L. Frosch, PhD; Vibha Bhatnagar, MD, MPH; Steven Tally, PhD; Charles J. Hamori, MD; Robert M. Kaplan, PhD Background: We conducted a randomized controlled [76.8%] reviewed) than those assigned to experimental trial to evaluate the effects of patient decision support groups (399 [86.7%] reviewed; P = .004). Greater reduc- Web sites on decision quality for men considering pros- tions in PSA screening from pretest to posttest were ob- tate cancer screening. served among participants assigned to the traditional de- cision aid (−9.1%) or chronic disease trajectory model Methods: Men older than 50 years (N = 611) were ran- (−8.7%), compared with participants assigned to the com- domly assigned to 1 of 4 Internet conditions: traditional bination (−5.3%) or control (−3.3%) groups (P = .047). didactic decision aid providing information about prostate- Preferences for watchful waiting increased significantly specific antigen (PSA) screening options and outcomes; in all 4 groups (baseline, 219 [35.8%]; follow-up, 303 chronic disease trajectory model for prostate cancer fol- [66.2%]; P .001). Knowledge scores were lowest for lowed by a time–trade-off exercise; both the didactic de- those assigned to public Web http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Internet Patient Decision Support

Download PDF
7 pages

Loading next page...
 
/lp/american-medical-association/internet-patient-decision-support-NC0eZzIUkX

References (28)

Publisher
American Medical Association
Copyright
Copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/archinternmed.2007.111
pmid
18299490
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL INVESTIGATION A Randomized Controlled Trial Comparing Alternative Approaches for Men Considering Prostate Cancer Screening Dominick L. Frosch, PhD; Vibha Bhatnagar, MD, MPH; Steven Tally, PhD; Charles J. Hamori, MD; Robert M. Kaplan, PhD Background: We conducted a randomized controlled [76.8%] reviewed) than those assigned to experimental trial to evaluate the effects of patient decision support groups (399 [86.7%] reviewed; P = .004). Greater reduc- Web sites on decision quality for men considering pros- tions in PSA screening from pretest to posttest were ob- tate cancer screening. served among participants assigned to the traditional de- cision aid (−9.1%) or chronic disease trajectory model Methods: Men older than 50 years (N = 611) were ran- (−8.7%), compared with participants assigned to the com- domly assigned to 1 of 4 Internet conditions: traditional bination (−5.3%) or control (−3.3%) groups (P = .047). didactic decision aid providing information about prostate- Preferences for watchful waiting increased significantly specific antigen (PSA) screening options and outcomes; in all 4 groups (baseline, 219 [35.8%]; follow-up, 303 chronic disease trajectory model for prostate cancer fol- [66.2%]; P .001). Knowledge scores were lowest for lowed by a time–trade-off exercise; both the didactic de- those assigned to public Web

Journal

JAMA Internal Medicine – American Medical Association

Published: Feb 25, 2008

There are no references for this article.